Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

Autoři	VERMA Subodh LUDKA Ondřej DHINGRA Nitish K BUTLER Javed ANKER Stefan D FERREIRA Joao Pedro FILIPPATOS Gerasimos JANUZZI James L LAM Carolyn S P SATTAR Naveed PEIL Barbara NORDABY Matias BRUECKMANN Martina POCOCK Stuart J ZANNAD Faiez PACKER Milton
Rok publikování	2022
Druh	Článek v odborném periodiku
Časopis / Zdroj	LANCET DIABETES & ENDOCRINOLOGY
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Doi	http://dx.doi.org/10.1016/S2213-8587(21)00292-8